Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 2 (2005), Issue 10 (October)

1. In vivo dosimetry with MOSFETs: dosimetric characterization and first clinical results in intraoperative radiotherapy.
   Int J Radiat Oncol Biol Phys, 63(3): 952-60. [Abstract] [Full-text]
2. Meat and fat intake as risk factors for pancreatic cancer: the multiethnic cohort study.
   J Natl Cancer Inst, 97(19): 1458-65. [Abstract] [Full-text]
3. Cytologic grade independently predicts survival of patients with pancreatic adenocarcinoma.
   Am J Clin Pathol, 124(5): 697-707. [Abstract] [Full-text]
4. Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous vasopressin in non-resectable pancreas cancer.
   Cancer Chemother Pharmacol, 56(6): 603-9. [Abstract] [Full-text]
5. Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis.
   J Pathol, 207(3): 301-12. [Abstract] [Full-text]
6. Effect of cyclophilin A on gene expression in human pancreatic cancer cells.
   Am J Surg, 190(5): 739-45. [Abstract] [Full-text]
7. Activation of p-ERK1/2 by nicotine in pancreatic tumor cell line AR42J: effects on proliferation and secretion.
   Am J Physiol Gastrointest Liver Physiol, 289(5): G926-34. [Abstract] [Full-text]
8. Determination of plasma trypsin-like activity in healthy subjects, patients with mild to moderate alcoholic chronic pancreatitis, and patients with nonjaundice pancreatic cancer.
   Dig Dis Sci, 50(11): 2165-9. [Abstract] [Full-text]
9. Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway.
   Carcinogenesis, 26(11): 1956-64. [Abstract] [Full-text]
10. Endostatin expression in a pancreatic cell line is modulated by a TNFalpha-dependent elastase.
    Br J Cancer, 93(9): 1024-8. [Abstract] [Full-text]
11. Overexpression of the small transmembrane and glycosylated protein SMAGP supports metastasis formation of a rat pancreatic adenocarcinoma line.
    Int J Cancer, 117(6): 913-22. [Abstract] [Full-text]
12. Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma.
    Cancer Chemother Pharmacol, 56(5): 510-20. [Abstract] [Full-text]
13. Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.
    J Clin Oncol, 23(31): 8033-40. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.